| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/23/2011 | US20110150927 Stabilisation of Viral Microparticles |
| 06/23/2011 | US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150837 Amphiphilic polymer functionalized by methionine |
| 06/23/2011 | US20110150820 Methods for covalently attaching a polymer to a methionine residue in proteins and peptides |
| 06/23/2011 | US20110150796 Precipitation polymerization in the presence of glycerin monostearate |
| 06/23/2011 | US20110150793 Clear or Translucent Composition |
| 06/23/2011 | US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
| 06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
| 06/23/2011 | CA2784847A1 Injectable polymer composition for use as a cell delivery vehicle |
| 06/23/2011 | CA2784827A1 Composition of dexibuprofen transdermal hydrogel |
| 06/23/2011 | CA2784826A1 Methods and compositions for stable liquid drug formulations |
| 06/23/2011 | CA2784785A1 Methods and compositions for treating inflammation of skin |
| 06/23/2011 | CA2784714A1 Liquid food composition |
| 06/23/2011 | CA2784712A1 Percutaneous absorption preparation comprising anti-dementia drug |
| 06/23/2011 | CA2784689A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | CA2784529A1 Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| 06/23/2011 | CA2784212A1 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs |
| 06/23/2011 | CA2784133A1 Felbinac-containing transdermally absorbable preparation |
| 06/23/2011 | CA2784093A1 Wise binding agents and epitopes |
| 06/23/2011 | CA2784015A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | CA2783964A1 Piroxicam-containing transdermally absorbable preparation |
| 06/23/2011 | CA2783891A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | CA2783615A1 Multifunctional zwitterionic polymer conjugates |
| 06/23/2011 | CA2783393A1 Dendritic high-molecular-weight polymer drug carriers and their conjugates with drugs especially for treatment of solid tumours |
| 06/23/2011 | CA2783296A1 Growth hormone composition |
| 06/23/2011 | CA2783000A1 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof |
| 06/23/2011 | CA2782815A1 Decellularized adipose tissue |
| 06/23/2011 | CA2776860A1 Pharmaceutical composition for treatment of dry eye syndrome |
| 06/23/2011 | CA2771188A1 Passive solid tumor-targeted pectin-doxorubicin prodrug and preparation method thereof |
| 06/22/2011 | EP2336218A1 Hydrophilic material, medical material and sustained release pharmaceutical material |
| 06/22/2011 | EP2336192A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336166A1 Compositions that inhibit proliferation of cancer cells |
| 06/22/2011 | EP2336162A1 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 06/22/2011 | EP2336147A2 A beta immunogenic peptide carrier conjugates and methods of producing same |
| 06/22/2011 | EP2335737A2 Artificial platelets |
| 06/22/2011 | EP2335736A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen |
| 06/22/2011 | EP2335735A1 Pharmaceutical composition for treatment of dry eye syndrome |
| 06/22/2011 | EP2335725A1 High concentration antibody and protein formulations |
| 06/22/2011 | EP2335719A1 Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |
| 06/22/2011 | EP2335704A1 Pharmaceutical composition comprising a strontium salt, vitamine D and a cyclodextrine |
| 06/22/2011 | EP2335703A1 Compositions and Methods for Preventing or Reducing Postoperative Ileus and Gastric Stasis in Mammals |
| 06/22/2011 | EP2335694A1 Thyroid hormone analogs and methods of use. |
| 06/22/2011 | EP2335691A1 Formulations comprising vardenafil with controlled release of active ingredient |
| 06/22/2011 | EP2335690A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes |
| 06/22/2011 | EP2335686A1 An aqueous intravenous nanosuspension with reduced adverse effects |
| 06/22/2011 | EP2334369A2 Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process |
| 06/22/2011 | EP2334338A2 Polymer conjugates of c-peptides |
| 06/22/2011 | EP2334337A1 Polymer conjugates of opioid growth factor peptides |
| 06/22/2011 | EP2334336A1 Polymer conjugates of osteocalcin peptides |
| 06/22/2011 | EP2334335A1 Polymer conjugates of cd-np peptides |
| 06/22/2011 | EP2334334A1 Polymer conjugates of nesiritide peptides |
| 06/22/2011 | EP2334333A1 Polymer conjugates of v681-like peptides |
| 06/22/2011 | EP2334324A2 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/22/2011 | EP2334323A2 Compositions and methods for the prevention of oxidative degradation of proteins |
| 06/22/2011 | EP2334290A1 Drug delivery system for econazole, moxifloxacin, and rifampicin |
| 06/22/2011 | EP2334287A2 Hot-melt extrusion of modified release multi-particulates |
| 06/22/2011 | EP2334285A1 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| 06/22/2011 | EP2334176A1 Topical formulations for treatment of neuropathy |
| 06/22/2011 | EP1888624B1 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 06/22/2011 | EP1817348B1 Per-6-guanidino-, -aminoalkylamino-and -guanidino-alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of dna and intracellular delivery |
| 06/22/2011 | EP1642132B1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 06/22/2011 | EP1341526B1 Pharmaceutical compositions for the oral delivery of calcitonin |
| 06/22/2011 | CN1835723B Deployable multifunctional hemostatic agent |
| 06/22/2011 | CN1820024B Novel poly(ethylene glycol) modified compounds and uses thereof |
| 06/22/2011 | CN102105553A Novel lipid dipeptide and gel |
| 06/22/2011 | CN102105498A Water-soluble acrylic acid salt polymer and gelling base |
| 06/22/2011 | CN102105173A Glycerophospholipids for the improvement of cognitive functions |
| 06/22/2011 | CN102105172A Peptides and their use as carriers into cancer cells |
| 06/22/2011 | CN102105171A Modified release niacin formulations |
| 06/22/2011 | CN102105156A Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 06/22/2011 | CN102105154A Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 06/22/2011 | CN102105143A Stable pharmaceutical composition containing tranexamic acid and ascorbic acid |
| 06/22/2011 | CN102105142A Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 06/22/2011 | CN102105141A Method of producing thrombin-immobilized bioabsorbable sheet preparation |
| 06/22/2011 | CN102105134A Stable injectable oil-in-water docetaxel nanoemulsion |
| 06/22/2011 | CN102105133A Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 06/22/2011 | CN102101888A Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof |
| 06/22/2011 | CN102101037A Preparation method of alginate/epsilon-polylysine/alginate biological microcapsule |
| 06/22/2011 | CN102101036A Alginate-epsilon-polylysine microcapsules and preparation and application thereof |
| 06/22/2011 | CN102100916A Freeze-drying liposome and preparation method and application thereof |
| 06/22/2011 | CN102100915A Chlorambucil multi-targeting medicine carrying system and preparation method and application thereof |
| 06/22/2011 | CN102100914A Artificial oil body carrier for targeted therapy of mastocarcinoma as well as preparation method and application thereof |
| 06/22/2011 | CN102100912A Administration composition and preparation method and using method thereof |
| 06/22/2011 | CN102100908A Protein composition |
| 06/22/2011 | CN102100907A Composition of oral pharmacologic active agent |
| 06/22/2011 | CN102100906A Medicinal preparation of exenatide and preparation method thereof |
| 06/22/2011 | CN102100905A Novel compound antimicrobial preparation |
| 06/22/2011 | CN102100904A Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 06/22/2011 | CN102100821A Medicinal cigarette external surface liniment for treating hemorrhoids, and preparation method and application thereof |
| 06/22/2011 | CN102100799A Anodynia disinfecting alcohol for injection |
| 06/22/2011 | CN102100773A Low dosage burnet root solid preparation |
| 06/22/2011 | CN102100758A Qingpeng gel for relieving pain and subdhing swelling and preparation method thereof |
| 06/22/2011 | CN102100733A Method for preparing red grass snore relieving capsules/tablets |
| 06/22/2011 | CN102100722A Chrysanthemum morifolium ramat general flavone pill and preparation method thereof |